You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

Prison Linked to Higher HIV Risk for Homeless

SUMMARY
Homeless individuals who have spent time in prison have a high likelihood of engaging in HIV-related risk behaviors including alcohol and drug use.

By Liz Highleyman

Incarceration and homeless are 2 socioeconomic factors known to be associated with elevated prevalence of HIV infection. It is currently estimated that about 2 million people are in jail or prison in the U.S.

As described in the February 2011 issue of AIDS and Behavior, Angela Hudson from the University of California Los Angeles School of Nursing and colleagues examined how these factors interact.

This was a subanalysis of a larger study evaluating the effectiveness of interventions to encourage completion of the hepatitis A and B vaccine series. There are currently no effective vaccines for hepatitis C virus (HCV) or HIV, which share transmission routes with hepatitis B.

The present analysis included 664 homeless adults living in shelters or on the streets in the Skid Row section of Los Angeles. Most were men and people already infected with hepatitis B virus (HBV) were not included. Data were collected between September 2003 and June 2006.

Participants were classified as either recently discharged from prison (out less than 1 year), released from prison at least 1 year ago, or never incarcerated. The researchers assessed socio-demographic characteristics including drug and alcohol use, sexual activity, mental health, and use of public assistance.

Results

More than one-third of homeless people (38%) reported ever spending time in prison.
16% had been recently discharged from prison.
Recently released individuals were younger, more likely to be men, and more likely to have a history of lifetime drug use, especially cocaine and methamphetamines.
About 20% of recently released individuals reported daily use of drugs and alcohol over the past 6 months.
Among people released at least 1 year ago, however, nearly half used drugs and alcohol daily.
More than half of those discharged in the past year spent time in a residential substance use treatment program during the previous 6 months.
No differences were noted across the 3 groups with regard to number of sexual partners.
Depressive symptom were common overall -- reported by at least 16% -- but were not significantly different across the 3 groups.

These findings led the study authors to conclude, "As risk for HCV and HIV co-infection continues among homeless ex-offenders, HIV/HCV prevention efforts are needed for this population.

"Among those discharged at least 1 year ago, there was generally more past 6 months daily drug and alcohol use compared to recently-released inmates," they elaborated in their discussion. "This finding suggests that, given time to readjust from prison life, drug and alcohol use continues after discharge from prison...Drug treatment is especially salient after release from prison, because it has been found to reduce recidivism rates among former inmates who received treatment compared to those who did not."

"Individuals with a dual history of incarceration and homelessness are at greater risk of engaging in behaviors, e.g. substance abuse, that increase their chance for HIV infection," they continued. "Both drug and alcohol treatment and increased stability via financial support can reduce risk for HIV infection and, thereby, improve health outcomes in this population, one of society's most vulnerable and marginalized."

Investigator affiliations: School of Nursing, University of California, Los Angeles, CA; Division of Infectious Diseases, University of California, Los Angeles, CA; Family Medicine, University of California, Los Angeles, CA.

5/24/11

Reference
AL Hudson, A Nyamathi, D Bhattacharya, et al. Impact of prison status on HIV-related risk behaviors. AIDS and Behavior 15(2):340-346 (free full text). February 2011.



 




















 









 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 Google Custom Search
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

CURRENT CME PROGRAMS

Noimage

Noimage

Noimage

Noimage
HIV Road Trip: Current Management Pathways and the Road Ahead

Noimage

Noimage

Noimage